These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17161063)

  • 1. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
    Boncoraglio GB; Bodini A; Brambilla C; Carriero MR; Ciusani E; Parati EA
    Cerebrovasc Dis; 2006; 22(2-3):191-5. PubMed ID: 16735791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
    Doggen CJ; Bertina RM; Cats VM; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific transcription of the PAI-1 gene in human astrocytes.
    Hultman K; Tjarnlund-Wolf A; Odeberg J; Eriksson P; Jern C
    Thromb Haemost; 2010 Nov; 104(5):998-1008. PubMed ID: 20806116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
    Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
    Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
    Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
    Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic gene polymorphism and ischemic stroke.
    Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
    Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S; Green FR; Scarabin PY; Nicaud V; Bara L; Dawson SJ; Humphries SE; Evans A; Luc G; Cambou JP
    Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.
    Nikolopoulos GK; Bagos PG; Tsangaris I; Tsiara CG; Kopterides P; Vaiopoulos A; Kapsimali V; Bonovas S; Tsantes AE
    Clin Chem Lab Med; 2014 Jul; 52(7):937-50. PubMed ID: 24695040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
    Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.
    Yende S; Angus DC; Ding J; Newman AB; Kellum JA; Li R; Ferrell RE; Zmuda J; Kritchevsky SB; Harris TB; Garcia M; Yaffe K; Wunderink RG;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1129-37. PubMed ID: 17761618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals.
    Verschuur M; Jellema A; Bladbjerg EM; M Feskens EJ; Mensink RP; Møller L; Vos HL; de Maat MP
    Atherosclerosis; 2005 Aug; 181(2):275-84. PubMed ID: 16039281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women.
    Hindorff LA; Schwartz SM; Siscovick DS; Psaty BM; Longstreth WT; Reiner AP
    J Cardiovasc Risk; 2002 Apr; 9(2):131-7. PubMed ID: 12006921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.